A 9-year-old boy who diagnosed with Duchenne muscular dystrophy at age 4 was the first to receive an experimental gene therapy and is now walking and running faster than ever. Six of eight other boys who received two different doses of the gene therapy were stronger and heartier a year after treatment, and a larger clinical trial is expected to start this year.
Sign up for FasterCures SmartBrief
Medical research news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.